Ocular Therapeutix, Inc. OCUL
$7.29
-4.95%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 4 | OWNERSHIP DOCUMENT | 2026-09-02 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-08-26 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-08-26 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-08-26 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-08-26 | View → |
| 10-Q | 10-Q | 2026-08-03 | View → |
| 8-K | FORM 8-K | 2026-08-03 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-06-18 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-06-12 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-06-12 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-06-12 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-06-12 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-06-12 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-06-12 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-06-12 | View → |
| 8-K | FORM 8-K | 2026-06-12 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-06-05 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-05-28 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-05-28 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-05-28 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-05-28 | View → |
| 10-Q | 10-Q | 2026-05-05 | View → |
| 8-K | FORM 8-K | 2026-05-05 | View → |
| DEF 14A | DEF 14A | 2026-04-30 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-04-13 | View → |
| 8-K | FORM 8-K | 2026-02-27 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-02-25 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-02-25 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-02-25 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-02-25 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-02-24 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-02-24 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-02-17 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-02-17 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-02-17 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-02-17 | View → |
| 10-K | 10-K | 2026-02-05 | View → |
| 8-K | FORM 8-K | 2026-02-05 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-02-04 | View → |
| 4 | OWNERSHIP DOCUMENT | 2026-01-26 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $7.29
- Market Cap
- $1.68 billion
- 52-Week Range
- $6.23 – $16.44
- Average Volume
- 2.92 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.